Next Article in Journal
Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
Next Article in Special Issue
Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees
Previous Article in Journal
Complete (Humoral and Cellular) Response to Vaccination against COVID-19 in a Group of Healthcare Workers-Assessment of Factors Affecting Immunogenicity
Previous Article in Special Issue
Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection
 
 
Article

Article Versions Notes

Vaccines 2022, 10(5), 712; https://doi.org/10.3390/vaccines10050712
Action Date Notes Link
article xml file uploaded 30 April 2022 14:02 CEST Original file -
article xml uploaded. 30 April 2022 14:02 CEST Update https://www.mdpi.com/2076-393X/10/5/712/xml
article pdf uploaded. 30 April 2022 14:02 CEST Version of Record https://www.mdpi.com/2076-393X/10/5/712/pdf
article html file updated 30 April 2022 14:03 CEST Original file -
article supplementary file uploaded. 13 May 2022 16:02 CEST - https://www.mdpi.com/2076-393X/10/5/712#supplementary
article html file updated 13 May 2022 16:04 CEST Update -
article html file updated 2 August 2022 21:47 CEST Update https://www.mdpi.com/2076-393X/10/5/712/html
Back to TopTop